NCT02178787 UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation Status COMPLETED Phase N/A
NCT02175459 Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy Status RECRUITING Phase N/A
NCT02172313 Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02166372 Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery Status RECRUITING Phase N/A
NCT02165579 Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis Status COMPLETED Phase N/A
NCT02165228 Strategies for Inflammation and Cardiovascular Disease (CVD) Prevention Status COMPLETED Phase NA
NCT02162407 A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin Status COMPLETED Phase PHASE1
NCT02161588 A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects Status COMPLETED Phase PHASE1
NCT02158442 Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients Status COMPLETED Phase PHASE2
NCT02156037 An RCT Evaluation of a Diabetes Dashboard Team Model in Primary Care Status COMPLETED Phase NA
NCT02155023 Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors Status COMPLETED Phase NA
NCT02151188 Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response Status COMPLETED Phase NA
NCT02150109 Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study) Status COMPLETED Phase NA
NCT02148861 A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02147431 A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1